B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

NEU2

MOLECULAR TARGET

neuraminidase 2

UniProt: Q9Y3R4NCBI Gene: 47592 compounds

NEU2 (neuraminidase 2) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting NEU2

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1neu5ac2en3.7642
2Zanamivir2.4010

About NEU2 as a Drug Target

NEU2 (neuraminidase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented NEU2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

NEU2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.